RxDoctor Payments Data

James Buchanan, MD

Family Medicine · Farragut, TNNPI 1154310357

Payments from drug & device makers

$13,585in general payments, 2019–2025

Across 824 payments — averaging $16.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Novo Nordisk$1K
  • Johnson & Johnson$1K
  • Pfizer$1K
  • Boehringer Ingelheim$668
  • Lilly USA, LLC$666
  • plus $7K from 54 others

What the payments were for

  • Food & beverage$13,574100%
  • Education$120%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)143$1,841
Novo Nordisk97$1,357
Johnson & Johnson18$1,117
Pfizer93$1,115
Boehringer Ingelheim30$668
Lilly USA, LLC42$666
Amgen(2 entities)47$660
AstraZeneca28$566
Abbott29$514
Merck33$415
GSK24$391
Amarin Pharma, Inc.25$378
Otsuka America Pharmaceutical, Inc.19$325
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)11$229
Bayer14$222
Eisai Inc.8$214
Lundbeck LLC10$202
Takeda Pharmaceuticals U.S.A., Inc.13$183
Astellas Pharma US Inc9$169
Silk Road Medical, Inc.1$147
Novartis8$134
Sanofi-aventis U.S. LLC9$133
Heartflow, Inc.1$132
Gilead8$113
E.r. Squibb & Sons, L.L.C.6$104
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC6$91
Viiv Healthcare Company5$91
Esperion Therapeutics, Inc.5$90
Kowa Pharmaceuticals America, Inc.6$79
Antares Pharma, Inc.5$76
Exact Sciences5$75
Boston Scientific3$71
Arbor Pharmaceuticals, Inc.4$68
Shield Therapeutics Inc4$66
Biohaven Pharmaceutical Holding Company Ltd.4$66
Theratechnologies Inc.3$64
Adlon Therapeutics L.p.4$64
Jazz Pharmaceuticals Inc.3$58
Teva Pharmaceuticals USA, Inc.3$47
Tris Pharma Inc2$41
Dynavax Technologies Corporation4$39
Nevro Corp.2$36
Azurity Pharmaceuticals, Inc.2$34
Axsome Therapeutics, Inc.2$32
Dexcom, Inc.2$30
Medtronic(2 entities)2$27
Sumitomo Pharma America, Inc.2$23
Genentech USA, Inc.1$23
Verona Pharma, Inc.1$20
Seqirus USA Inc1$20
Philips North America LLC1$20
Phathom Pharmaceuticals, Inc.1$19
Kyowa Kirin, Inc.1$19
Irhythm Technologies, Inc.1$17
Supernus Pharmaceuticals, Inc.1$17
Halozyme Inc1$16
Shire North American Group Inc1$15
VBI Vaccine (delaware) Inc.1$15
Idorsia Pharmaceuticals US Inc1$15
Xeris Pharmaceuticals, Inc.1$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,585 in reported general payments places this provider in the 95th percentile of 2,087 family medicine providers in Tennessee.

See all family medicine providers in Tennessee

Medicare billing

Part B allowed, 2024
$171,803
Medicare patients
305
Services billed
18,138

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide87$99,273
EliquisApixaban67$73,806
LinzessLinaclotide40$66,661
JardianceEmpagliflozin52$60,164
Trelegy ElliptaFluticasone/Umeclidin/Vilanter55$46,992
MounjaroTirzepatide27$28,671
Tresiba Flextouch U-200Insulin Degludec14$25,611
Nurtec OdtRimegepant Sulfate14$24,572
Breztri AerosphereBudesonide/Glycopyr/Formoterol21$18,162
FarxigaDapagliflozin Propanediol17$15,682
MyrbetriqMirabegron15$15,270
XareltoRivaroxaban15$14,084
JanumetSitagliptin Phos/Metformin Hcl11$7,965
Repatha SureclickEvolocumab13$6,865
Spiriva RespimatTiotropium Bromide13$6,389

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Novolog$1,357$101,503102 claims
PfizerEliquis, Nurtec Odt$1,115$98,37781 claims
AbbVieLinzess, Synthroid$1,841$68,40485 claims
Boehringer IngelheimJardiance, Spiriva Respimat$668$66,55365 claims
GSKTrelegy Ellipta, Shingrix, Arexvy$391$54,24083 claims
AstraZenecaBreztri Aerosphere, Farxiga$566$33,84438 claims
Lilly USA, LLCMounjaro$666$28,67127 claims
Astellas Pharma US IncMyrbetriq$169$15,27015 claims
Johnson & JohnsonXarelto$1,117$14,08415 claims
MerckJanumet$415$7,96511 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,087 family medicine providers in Tennessee.

Other family medicine in Farragut

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →